Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience

Abstract

In the literature, there is an abundance of promising data on the outcome of allogeneic stem cell transplantation (SCT) in patients with Fanconi anemia (FA); however, the data on the outcome of FA patients who present with myelodysplasia and/or abnormal clone are sketchy as the entity itself is a rare one, although, it is believed that the presence of any of these factors confers a worse prognosis on the outcome of the transplant. This is an update of our experience in 11 such patients who underwent SCT at King Faisal Specialist Hospital and Research Center; 10 from the matched and related donors and 1 from a partially matched unrelated cord blood unit; the conditioning was with the same regimen consisting of cyclophosphamide (total of 20 mg/kg), anti-thymocyte globulin (total dose 160 mg/kg of the equine product or 52 mg/kg of the rabbit product) and total-body irradiation at 450 cGy. Ten patients remain currently alive, well and with no evidence of disease, with a median follow-up of almost 4 years.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kohli-Kumar M, Morris C, DeLaat C, Sambrano J, Masterson M, Mueller R et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050–2054.

    CAS  PubMed  Google Scholar 

  2. Socié G, Devergie A, Girinski T, Piel G, Ribaud P, Esperou H et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998; 103: 249–255.

    Article  PubMed  Google Scholar 

  3. Ayas M, Solh H, Mustafa MM, Al-Mahr M, Al-Fawaz I, Al-Jefri A et al. Bone marrow transplantation from matched siblings in patients with fanconi anemia utilizing low-dose cyclophosphamide, thoracoabdominal radiation and antithymocyte globulin. Bone Marrow Transplant 2001; 27: 139–143.

    Article  CAS  PubMed  Google Scholar 

  4. Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Al-Seraihi A, Tbakhi A et al. Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy. Bone Marrow Transplant 2005; 35: 463–466.

    Article  CAS  PubMed  Google Scholar 

  5. Zanis-Neto J, Flowers ME, Medeiros CR, Bitencourt MA, Bonfim CM, Setúbal DC et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 2005; 130: 99–106.

    Article  CAS  PubMed  Google Scholar 

  6. Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT . Fanconi anemia. Myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 2000; 117: 125–131.

    Article  CAS  Google Scholar 

  7. Tischkowitz M, Dokal I . Fanconi anaemia and leukaemia—clinical and molecular aspects. Br J Haematol 2004; 126: 176–191.

    Article  CAS  PubMed  Google Scholar 

  8. Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, Moussa E, Karaoui M et al. Allogeneic stem cell transplantation in patients with Fanconi's anemia and myelodysplasia or leukemia utilizing low-dose cyclophosphamide and total body irradiation. Bone Marrow Transplant 2004; 33: 15–17.

    Article  CAS  PubMed  Google Scholar 

  9. Ikushima S, Hibi S, Todo S, Sawada T, Matsumoto Y, Iwami H et al. Successful allogeneic bone marrow transplantation in a case with myelodysplastic syndrome which developed following Fanconi anemia. Bone Marrow Transplant 1995; 16: 621–624.

    CAS  PubMed  Google Scholar 

  10. Philpott NJ, Marsh JCW, Kumaran TO, Yardumian A, Lawler M, McCann SR et al. Successful bone marrow transplant for Fanconi anaemia in transformation. Bone Marrow Transplant 1994; 14: 151–153.

    CAS  PubMed  Google Scholar 

  11. Ayas M, Al-Mahr M, Al-Jefri A, Rifai S, Solh H . Does adding ATG to the GVHD prophylaxis regimen help reduce its incidence? Bone Marrow Transplant 2003; 31: 311.

    Article  CAS  PubMed  Google Scholar 

  12. Flowers M, Doney KC, Storb R, Deeg HJ, Sanders JE, Sullivan KM et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167–173.

    CAS  PubMed  Google Scholar 

  13. Berger R, Bernheim A, Gluckman E, Gisselbrecht C . In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980; 45: 565–568.

    Article  CAS  PubMed  Google Scholar 

  14. Gluckman E, Devergie A, Dutreix J . Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54: 431–440.

    Article  CAS  PubMed  Google Scholar 

  15. De La Fuente J, Reiss S, McCloy M, Vulliamy T, Roberts IAG, Rahemtulla A et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant 2003; 32: 653–656.

    Article  CAS  PubMed  Google Scholar 

  16. George B, Mathews V, Shaji RV, Srivastava V, Srivastava A, Chandy M . Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia. Bone Marrow Transplant 2005; 35: 341–343.

    Article  CAS  PubMed  Google Scholar 

  17. Tan PL, Wagner JE, Auerbach AD, DeFor TE, Slungaard A, MacMillan ML . Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatric Blood and Cancer 2006; 46: 630–636.

    Article  PubMed  Google Scholar 

  18. Bitan M, Or R, Shapira MY, Aker M, Resnick IB, Ackerstein A et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant 2006; 12: 712–718.

    Article  CAS  Google Scholar 

  19. Mehta PA, Ileri T, Harris RE, Williams DA, Mo J, Smolarek T et al. Chemotherapy for myeloid malignancy in children with Fanconi anemia. Pediatr Blood Cancer 2007; 48: 668–672.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Ayas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayas, M., Al-Jefri, A., Al-Seraihi, A. et al. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience. Bone Marrow Transplant 41, 261–265 (2008). https://doi.org/10.1038/sj.bmt.1705903

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705903

Keywords

This article is cited by

Search

Quick links